WHOM will be doing the human testing? And then get the protocol rolled out to all stroke hospitals? With NO stroke leadership I'm afraid nothing will be done, other promising animal research never seems to get to human testing and protocols.
With your elevated risk of
Alzheimers/dementia you'll want your doctor following this carefully.
Is your doctor ensuring further studies occur?
Or is your doctor incompetently WAITING FOR SOMEONE ELSE TO SOLVE THE PROBLEM?
Your risk of dementia, has your doctor told you of this?
1. A documented 33% dementia chance post-stroke from an Australian study? May 2012.
2. Then this study came out and seems to have a range from 17-66%. December 2013.`
3. A 20% chance in this research. July 2013.
4. Dementia Risk Doubled in Patients Following Stroke September 2018
What is your doctor's EXACT PROTOCOL TO PREVENT DEMENTIA?
The latest here:
Flavonoids from Stems and Leaves of Scutellaria baicalensis Georgi Improve Composited Aβ-induced Alzheimer's Disease Model Rats' Memory and Neuroplasticity Disorders
- PMID: 36200197
- DOI: 10.2174/1386207325666221003092627
Abstract
Aim: To investigate the effects and mechanism of flavonoids from stems and leaves of Scutellaria baicalensis Georgi (SSF) on the disorders in learning and memory and neuroplasticity induced by beta amyloid 25-35 (Aβ25-35) combined with aluminum trichloride (AlCl3) and human recombinant transfer factor-β1 (RHTGF-β1) (composited Aβ) in rats.
Methods: A rat Alzheimer's disease (AD) model was established by intracerebroventricular injection of Aβ25-35 combined with AlCl3 and RHTGF-β1. The successful AD model of rats was screened with Morris water maze. The successful model rats were randomly divided into a model group and three doses of SSF treated group. The Morris water maze was used to detect the rats' learning and memory abilities. The real-time fluorescence quantitative (qPCR) was applied to assay the mRNA expressions of CaM, CamkIV and Ferritin, as well as the neuroplasticity factors of HuB, HuC and HuD. The Western blotting was used to measure the protein expressions of CaM, CamkIV, HuB/D, HuC+HuD and Ferritin in CaM-CamkIV-CREB signal pathway.
Results: Compared with sham group, the abilities of learning and memory in the model group were significantly impaired (P<0.01), and the mRNA or protein expressions of CaM, CamkIV, HuB, HuC, HuD, HuB/D, HuC+HuD and Ferritin in CaM-CamkIV-CREB signal pathway were abnormal changed in model group. However, the three doses of SSF can differently ameliorated the impaired learning and memory and regulate the abnormal expressions of mRNA or protein in rats' CaM, CamkIV, HuB, HuC, HuD, HuB/D, HuC+HuD and Ferritin induced by composited Aβ.
Conclusion: The improvement of SSF on the learning and memory disorder induced by composited Aβ is primarily derived from the positive regulation in CaM-CamkIV-CREB signal pathway and activation in neuroplasticity.
Keywords: Alzheimer's disease; CaM-CamkIV-CREB signal pathway; Flavonoids from stems and leaves of Scutellaria baicalensis Georgi; learning and memory; neuroplasticity.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
No comments:
Post a Comment